News Headlines Article

‘Overtreatment’ Debate Circles Back to Lung Cancer Screening
HealthLeaders Media

The debate over lung cancer screening jumped out of the medical journals and on to the stage at an event called “The Diagnostic Debate” at The Liberty Hotel in Boston Oct. 15.

The half-day meeting, sponsored by The Atlantic magazine and Siemens, a major manufacturer of imaging equipment used to screen for disease. Gregory Sorensen, the CEO of Siemens Healthcare North America opened the session by challenging the notion that screening drives overdiagnosis.